par Bedard, Philippe L;Cardoso, Fatima ;Piccart-Gebhart, Martine
Référence Journal of mammary gland biology and neoplasia, 14, 1, page (55-66)
Publication Publié, 2009-03
Article révisé par les pairs
Titre:
  • Stemming resistance to HER-2 targeted therapy.
Auteur:Bedard, Philippe L; Cardoso, Fatima; Piccart-Gebhart, Martine
Informations sur la publication:Journal of mammary gland biology and neoplasia, 14, 1, page (55-66)
Statut de publication:Publié, 2009-03
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:Breast neoplasms
Cancer stem cells
erbB-2 receptor
Monoclonal antibodies
Protein-tyrosine kinases
MeSH keywords:Animals
Antineoplastic Agents -- therapeutic use
Breast Neoplasms -- drug therapy
Breast Neoplasms -- metabolism
Breast Neoplasms -- pathology
Clinical Trials, Phase III as Topic
Drug Resistance, Neoplasm
Humans
Neoplastic Stem Cells -- drug effects
Neoplastic Stem Cells -- metabolism
Receptor, erbB-2 -- antagonists & inhibitors
Receptor, erbB-2 -- metabolism
Treatment Outcome
Note générale:Journal Article
Review
Langue:Anglais
Identificateurs:urn:issn:1083-3021
info:doi/10.1007/s10911-009-9116-x
info:scp/62549103323
info:pmid/19259796